Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Start-up Series - Unicorn Quest: Innovators in Medical and Pharma" report has been added to ResearchAndMarkets.com's offering.The report highlights...
-
DUBLIN, Feb. 03, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a...
-
Primary endpoint met, GH001 led to an ultra-rapid anti-depressant effect with a significant placebo-adjusted MADRS reduction from baseline of -15.5 on Day 8 (p<0.0001)The majority of the patients...
-
DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
-
ORION OYJ LEHDISTÖTIEDOTE 30.1.2025 KLO 16.00 Orion ja Invenra solmivat tutkimuspalvelu- ja kaupallisen lisenssisopimuksen syöpähoitoihin tarkoitettujen innovatiivisten...
-
ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific...
-
Dublin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Compression Therapy Market Outlook to 2033 - Pneumatic Compression Therapy and Static Compression Therapy" report has been added to ...
-
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
-
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
-
Virtual Science AI Unveils Real-Time Intelligent Q&A Feature for Life Science Insights